Header Logo

Connection

Farahnak Assadi to Rituximab

Back to Details
This is a "connection" page, showing publications Farahnak Assadi has written about Rituximab.
Farahnak Assadi
Connection Strength
0.202
Rituximab
  1. Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid-resistant nephrotic syndrome. Pharmacotherapy. 2022 09; 42(9):690-696.
    View in: PubMed
    Score: 0.202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.